FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

422353003: Prolonged-release oral suspension (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2673153018 Extended-release oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3564858015 Prolonged-release oral suspension (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3564867015 Prolonged-release oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral suspension (dose form) Is a Oral suspension false Inferred relationship Some
Prolonged-release oral suspension (dose form) Is a Oral dose form true Inferred relationship Some
Prolonged-release oral suspension (dose form) Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. true Inferred relationship Some
Prolonged-release oral suspension (dose form) Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. true Inferred relationship Some
Prolonged-release oral suspension (dose form) Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release oral suspension (dose form) Has basic dose form (attribute) A liquid dose form consisting of a suspension of fine particles in a suitable vehicle. true Inferred relationship Some
Prolonged-release oral suspension (dose form) Has dose form transformation (attribute) No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Clonidine hydrochloride 100 microgram/mL prolonged-release oral suspension Has manufactured dose form True Prolonged-release oral suspension (dose form) Inferred relationship Some

This concept is not in any reference sets

Back to Start